A study regarding the quality of life evaluation in patients with terminal pancreatic cancer

5^th World Congress on Cancer Therapy

September 28-30, 2015 Atlanta, USA

Alin Ciobica2, Daniel Timofte1, Radu Danila1, Roxana Livadaru1, Corneliu Diaconu1, Emil Anton1, and Lidia Ionescu1

1University of Medicine and Pharmacy â�?�?Gr.T.Popaâ�? Iasi, Romania
2Alexandru Ioan Cuzaâ�? University, Iasi, Romania

Posters-Accepted Abstracts: J Cancer Sci Ther

Abstract :

Lately, the Quality of Life (QOL) has increasingly become a widely used parameter in Oncology Clinical Research, and for over a decade, it is considered a very important tool used to establish valid and accurate research instruments for the patients with cancer. In this way, in the present report we will describe some aspects regarding the quality of life after pancreaticduodenectomy, an aspect which increasingly relevant especially since lately the mortality by pancreatic-duodenectomy is significantly decreasing, and interests are directing towards the postoperative morbidity. Thus, we conclude here that these survivors of pancreatic-duodenectomy should be monitored appropriately in regards to their quality of life. Also, the relevance of these studies in the context of the death denial and the maintaining for the quality of life in the pre-terminal stages are presented and discussed extensively. Terminal status denial in these patients is not a static or pathological concept, but rather a dynamic and natural condition, the majority of patients solving their problems and eventually accepting their disease terminal aspect/sense. However, it is clear that a perfected and effective relief of the physical, psychosocial and spiritual symptoms and fear attenuation is necessary in these terminal stages.

Biography :

Email: alinmimi@yahoo.com